Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy

Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer

Women with luminal A subtype of breast cancer did not benefit from adjuvant chemotherapy

Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer

ASH 2015: Highlights in mantle cell lymphoma

ASH 2015: Novel combination approaches for multiple myeloma

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

Highlights of Cancer Prevention Europe

Cancer Core Europe: what has been achieved one year on?

Cancer Prevention Europe

Cancer Core Europe: one year on (full version)

Removing unknowing financial investments from the tobacco industry